• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Breast Cancer Incidence and Mortality by Molecular Subtype: Statewide Age and Racial/Ethnic Disparities in New Jersey.按分子亚型划分的乳腺癌发病率和死亡率:新泽西州全州范围的年龄及种族/族裔差异
Cancer Health Disparities. 2019;3:e1-e17. doi: 10.9777/chd.2019.1012. Epub 2019 Aug 19.
2
State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.美国女性中三阴性乳腺癌发病率的种族和民族差异的州际变化。
JAMA Oncol. 2023 May 1;9(5):700-704. doi: 10.1001/jamaoncol.2022.7835.
3
Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.2010 年至 2015 年美国不同种族/族裔乳腺癌亚型发病率和分布的变化。
JAMA Netw Open. 2020 Oct 1;3(10):e2020303. doi: 10.1001/jamanetworkopen.2020.20303.
4
Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations.年轻非裔美国女性中三阴性乳腺癌的基于人群的更高发病率:对乳腺癌筛查建议的影响。
Cancer. 2011 Jun 15;117(12):2747-53. doi: 10.1002/cncr.25862. Epub 2011 Jan 10.
5
Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.田纳西州孟菲斯市非裔美国女性中不同乳腺肿瘤亚型生存结果的种族差异。
Cancer Med. 2017 Jul;6(7):1776-1786. doi: 10.1002/cam4.1117. Epub 2017 Jun 14.
6
Impact of molecular subtype and race on HR+, HER2- breast cancer survival.分子亚型和种族对 HR+、HER2- 乳腺癌生存的影响。
Breast Cancer Res Treat. 2021 Oct;189(3):845-852. doi: 10.1007/s10549-021-06342-0. Epub 2021 Jul 31.
7
Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.一项基于人群的研究中社会人口学和临床病理因素与乳腺癌亚型之间的关联。
Cancer Causes Control. 2015 Dec;26(12):1737-50. doi: 10.1007/s10552-015-0667-4. Epub 2015 Sep 16.
8
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.乳腺癌生存中的种族和民族差异:肿瘤特征、社会人口统计学及治疗因素的中介作用
J Clin Oncol. 2015 Jul 10;33(20):2254-61. doi: 10.1200/JCO.2014.57.1349. Epub 2015 May 11.
9
Health Insurance Coverage and Racial/Ethnic Disparities in US Childhood and Adolescent Cancer Survival.医疗保险覆盖范围与美国儿童和青少年癌症生存的种族/民族差异。
J Pediatr. 2023 Jun;257:113378. doi: 10.1016/j.jpeds.2023.02.022. Epub 2023 Mar 6.
10
Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.评估三阴性乳腺癌女性在治疗和死亡率方面的种族/民族差异。
JAMA Oncol. 2021 Jul 1;7(7):1016-1023. doi: 10.1001/jamaoncol.2021.1254.

引用本文的文献

1
Unraveling the role of stromal disruption in aggressive breast cancer etiology and outcomes.揭示基质破坏在侵袭性乳腺癌病因及预后中的作用。
J Natl Cancer Inst. 2025 May 14. doi: 10.1093/jnci/djaf070.
2
Racial disparities in triple-negative breast cancer: insights from the E5103 trial and beyond.三阴性乳腺癌中的种族差异:来自E5103试验及其他研究的见解
Gland Surg. 2025 Feb 28;14(2):252-256. doi: 10.21037/gs-24-460. Epub 2025 Feb 25.
3
Racial Differences in Breast Cancer Survival Between Black and White Women According to Tumor Subtype: A Systematic Review and Meta-Analysis.根据肿瘤亚型分析黑人和白人女性乳腺癌生存的种族差异:系统评价和荟萃分析。
J Clin Oncol. 2024 Nov 10;42(32):3867-3879. doi: 10.1200/JCO.23.02311. Epub 2024 Sep 17.
4
EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth.EZH2 PROTACs 靶向 EZH2 和 FOXM1 相关的致癌节点,抑制乳腺癌细胞生长。
Oncogene. 2024 Aug;43(36):2722-2736. doi: 10.1038/s41388-024-03119-9. Epub 2024 Aug 7.
5
WD Repeat and HMG Box DNA Binding Protein 1: An Oncoprotein at the Hub of Tumorigenesis and a Novel Therapeutic Target.WD 重复和 HMG 盒 DNA 结合蛋白 1:一种位于肿瘤发生中心的癌蛋白和一个新的治疗靶点。
Int J Mol Sci. 2023 Aug 6;24(15):12494. doi: 10.3390/ijms241512494.
6
Rutgers Youth Enjoy Science Program: Reducing Cancer Health Disparities by Reducing Education Inequities.罗格斯青年科学体验计划:通过减少教育不平等来缩小癌症健康差距。
J STEM Outreach. 2022 Aug;5(2). doi: 10.15695/jstem/v5i2.09. Epub 2022 Aug 31.
7
Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer.早期激素受体阳性、HER2阴性、无淋巴结转移乳腺癌患者中性粒细胞与淋巴细胞比值与Oncotype Dx复发评分的相关性
Cancer Manag Res. 2021 Dec 29;13:9411-9420. doi: 10.2147/CMAR.S343549. eCollection 2021.
8
The Growth Suppression Activity of Diosmin and PGV-1 Co-Treatment on 4T1 Breast Cancer Targets Mitotic Regulatory Proteins.地奥司明与 PGV-1 联合治疗对 4T1 乳腺癌靶向有丝分裂调节蛋白的生长抑制作用。
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2929-2938. doi: 10.31557/APJCP.2021.22.9.2929.
9
Relationship of established risk factors with breast cancer subtypes.已确立的风险因素与乳腺癌亚型的关系。
Cancer Med. 2021 Sep;10(18):6456-6467. doi: 10.1002/cam4.4158. Epub 2021 Aug 31.
10
Risk factors for breast cancer subtypes among Black women undergoing screening mammography.黑人女性接受筛查性乳房 X 光检查的乳腺癌亚型的风险因素。
Breast Cancer Res Treat. 2021 Oct;189(3):827-835. doi: 10.1007/s10549-021-06340-2. Epub 2021 Aug 3.

本文引用的文献

1
Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis.新泽西州女性乳腺癌确诊时的分期差异:一项时空分析。
J Public Health Manag Pract. 2017 Sep/Oct;23(5):477-486. doi: 10.1097/PHH.0000000000000524.
2
Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.雌激素和孕激素受体阳性乳腺癌患者生存的种族差异:对降低乳腺癌死亡率差异的启示
Breast Cancer Res Treat. 2017 Jun;163(2):321-330. doi: 10.1007/s10549-017-4166-z. Epub 2017 Mar 1.
3
Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013.利用监测、流行病学与最终结果计划(1992 - 2013年)的数据,按亚型划分的癌症发病率和生存趋势
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):632-641. doi: 10.1158/1055-9965.EPI-16-0520. Epub 2016 Dec 12.
4
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.三阴性乳腺癌的总生存率和病因特异性生存率均低于非三阴性乳腺癌。
Breast Cancer Res Treat. 2017 Jan;161(2):279-287. doi: 10.1007/s10549-016-4059-6. Epub 2016 Nov 25.
5
Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women.非裔美国女性癌症家族史与乳腺癌亚型的关系
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):366-73. doi: 10.1158/1055-9965.EPI-15-1068. Epub 2015 Dec 31.
6
Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.绝经后非洲裔美国女性使用女性激素与雌激素受体阳性和阴性乳腺癌的关系
J Natl Cancer Inst. 2015 Nov 26;108(4). doi: 10.1093/jnci/djv361. Print 2016 Apr.
7
Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment.纽约和加利福尼亚州乳腺癌护理质量因种族/族裔和医疗补助登记情况而异。
Cancer. 2016 Feb 1;122(3):420-31. doi: 10.1002/cncr.29777. Epub 2015 Nov 4.
8
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.乳腺癌统计数据,2015:黑人和白人女性发病率趋同。
CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42. doi: 10.3322/caac.21320. Epub 2015 Oct 29.
9
Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.按激素受体和HER2状态划分的乳腺癌诊断与治疗中的种族差异。
Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1666-72. doi: 10.1158/1055-9965.EPI-15-0293. Epub 2015 Oct 13.
10
Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.一项基于人群的研究中社会人口学和临床病理因素与乳腺癌亚型之间的关联。
Cancer Causes Control. 2015 Dec;26(12):1737-50. doi: 10.1007/s10552-015-0667-4. Epub 2015 Sep 16.

按分子亚型划分的乳腺癌发病率和死亡率:新泽西州全州范围的年龄及种族/族裔差异

Breast Cancer Incidence and Mortality by Molecular Subtype: Statewide Age and Racial/Ethnic Disparities in New Jersey.

作者信息

Kulkarni Aishwarya, Stroup Antoinette M, Paddock Lisa E, Hill Stephanie M, Plascak Jesse J, Llanos Adana A M

机构信息

Department of Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

出版信息

Cancer Health Disparities. 2019;3:e1-e17. doi: 10.9777/chd.2019.1012. Epub 2019 Aug 19.

DOI:10.9777/chd.2019.1012
PMID:31440744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6706320/
Abstract

The objective of this study was to assess breast cancer incidence and mortality rates by molecular subtype for cases diagnosed in New Jersey. Data on all primary, histologically confirmed, invasive breast cancers diagnosed among women between January 1, 2008 and December 31, 2013 were retrieved from the New Jersey State Cancer Registry. Age-adjusted incidence rates were calculated for each subtype, by ageandrace/ethnicity. Logistic regression models, Cox proportional hazards models, and Kaplan Meier curves were used to describe the relative risks for breast cancer incidence, mortality, and survival, respectively. In this population-based sample of 32,770 breast cancer cases, non-Hispanic Blacks (NHBs) had the highest triple-negative breast cancer (TNBC) incidence rate (17.8 per 100,000, 95% CI 16.5-19.2) compared to other races/ethnicities. NHBs had also higher odds of TNBC (OR 2.1, 95% CI 1.95-2.36) and higher hazards of death when diagnosed with TNBC (HR 1.28, 95% CI 1.05-1.56), luminal A (HR 1.64, 95% CI 1.41-1.91), or luminal B (HR 1.54, 95% CI 1.10-2.15) than non-Hispanic Whites (NHWs). Younger women (20-39 years) had higher odds of TNBC (OR 1.77, 95% CI 1.54-2.02) and luminal B (OR 1.56, 95% CI 1.35-1.80) compared to women 50-64 years; minority women had higher odds of non-luminal HER2-expressing and lower odds of luminal A than NHWs. TNBC was associated with the poorest survival rates. These findings highlight a need for enhanced screening to promote earlier diagnosis and improve breast cancer outcomes, particularly in minorities and younger women, which will be essential for achieving health equity.

摘要

本研究的目的是评估新泽西州确诊病例按分子亚型划分的乳腺癌发病率和死亡率。从新泽西州癌症登记处检索了2008年1月1日至2013年12月31日期间诊断出的所有原发性、经组织学确诊的浸润性乳腺癌女性患者的数据。按年龄和种族/族裔计算了各亚型的年龄调整发病率。分别使用逻辑回归模型、Cox比例风险模型和Kaplan-Meier曲线来描述乳腺癌发病率、死亡率和生存率的相对风险。在这个基于人群的32770例乳腺癌病例样本中,与其他种族/族裔相比,非西班牙裔黑人(NHB)的三阴性乳腺癌(TNBC)发病率最高(每10万人中有17.8例,95%置信区间16.5-19.2)。NHB患TNBC的几率也更高(优势比2.1,95%置信区间1.95-2.36),并且在诊断为TNBC、腔面A型(风险比1.64,95%置信区间1.41-1.91)或腔面B型(风险比1.54,95%置信区间1.10-2.15)时,死亡风险高于非西班牙裔白人(NHW)。与50-64岁的女性相比,年轻女性(20-39岁)患TNBC(优势比1.77,95%置信区间1.54-2.02)和腔面B型(优势比1.56,95%置信区间1.35-1.80)的几率更高;少数族裔女性患非腔面HER2表达型乳腺癌的几率高于NHW,而患腔面A型乳腺癌的几率低于NHW。TNBC与最差的生存率相关。这些发现凸显了加强筛查以促进早期诊断和改善乳腺癌治疗效果的必要性,特别是在少数族裔和年轻女性中,这对于实现健康公平至关重要。